
Walter E. Webb
Examiner (ID: 5438, Phone: (571)270-3287 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612, 4133 |
| Total Applications | 1277 |
| Issued Applications | 576 |
| Pending Applications | 113 |
| Abandoned Applications | 605 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5766966
[patent_doc_number] => 20060018959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-26
[patent_title] => 'Solid drug for oral use'
[patent_app_type] => utility
[patent_app_number] => 10/538514
[patent_app_country] => US
[patent_app_date] => 2003-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9046
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20060018959.pdf
[firstpage_image] =>[orig_patent_app_number] => 10538514
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/538514 | Solid drug for oral use | Dec 10, 2003 | Abandoned |
Array
(
[id] => 7151024
[patent_doc_number] => 20040171594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Use of bis-acid(5-androsten-17-one-3beta-hydroxyl)diester for manufacture pharmaceuticals'
[patent_app_type] => new
[patent_app_number] => 10/480173
[patent_app_country] => US
[patent_app_date] => 2003-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7047
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171594.pdf
[firstpage_image] =>[orig_patent_app_number] => 10480173
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/480173 | Use of bis-acid(5-androsten-17-one-3beta-hydroxyl)diester for manufacture pharmaceuticals | Dec 8, 2003 | Abandoned |
Array
(
[id] => 5193466
[patent_doc_number] => 20070081950
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-12
[patent_title] => 'Solid oral tooth whitening confectionary composition'
[patent_app_type] => utility
[patent_app_number] => 10/582223
[patent_app_country] => US
[patent_app_date] => 2003-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4947
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20070081950.pdf
[firstpage_image] =>[orig_patent_app_number] => 10582223
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/582223 | Solid oral tooth whitening confectionary composition | Dec 7, 2003 | Abandoned |
Array
(
[id] => 5710134
[patent_doc_number] => 20060051479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Homogeneous solid granules containing carotenoids'
[patent_app_type] => utility
[patent_app_number] => 10/536182
[patent_app_country] => US
[patent_app_date] => 2003-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3589
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051479.pdf
[firstpage_image] =>[orig_patent_app_number] => 10536182
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/536182 | Homogeneous solid granules containing carotenoids | Dec 7, 2003 | Abandoned |
Array
(
[id] => 5834348
[patent_doc_number] => 20060246178
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Fermented milk product comprising tripeptide vpp and/or ipp'
[patent_app_type] => utility
[patent_app_number] => 10/541477
[patent_app_country] => US
[patent_app_date] => 2003-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5523
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246178.pdf
[firstpage_image] =>[orig_patent_app_number] => 10541477
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/541477 | Fermented milk product comprising tripeptide vpp and/or ipp | Dec 2, 2003 | Abandoned |
Array
(
[id] => 8161528
[patent_doc_number] => 08172395
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-08
[patent_title] => 'Medical devices having antimicrobial coatings thereon'
[patent_app_type] => utility
[patent_app_number] => 10/722256
[patent_app_country] => US
[patent_app_date] => 2003-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11001
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/172/08172395.pdf
[firstpage_image] =>[orig_patent_app_number] => 10722256
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/722256 | Medical devices having antimicrobial coatings thereon | Nov 24, 2003 | Issued |
Array
(
[id] => 7305979
[patent_doc_number] => 20040116380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Underivatized, aqueous soluble beta(1-3) glucan, composition and method of making same'
[patent_app_type] => new
[patent_app_number] => 10/719432
[patent_app_country] => US
[patent_app_date] => 2003-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10601
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20040116380.pdf
[firstpage_image] =>[orig_patent_app_number] => 10719432
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/719432 | Underivatized, aqueous soluble beta(1-3) glucan, composition and method of making same | Nov 20, 2003 | Abandoned |
Array
(
[id] => 7470111
[patent_doc_number] => 20040102512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Statins (HMG-CoA reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent'
[patent_app_type] => new
[patent_app_number] => 10/718731
[patent_app_country] => US
[patent_app_date] => 2003-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 16848
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20040102512.pdf
[firstpage_image] =>[orig_patent_app_number] => 10718731
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/718731 | Statins (HMG-CoA reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent | Nov 19, 2003 | Abandoned |
Array
(
[id] => 6978642
[patent_doc_number] => 20050288360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Nutraceutical compositions comprising epigallocatechin gallate and raspberry ketone'
[patent_app_type] => utility
[patent_app_number] => 10/536374
[patent_app_country] => US
[patent_app_date] => 2003-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4462
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20050288360.pdf
[firstpage_image] =>[orig_patent_app_number] => 10536374
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/536374 | Nutraceutical compositions comprising epigallocatechin gallate and raspberry ketone | Nov 19, 2003 | Abandoned |
Array
(
[id] => 7347531
[patent_doc_number] => 20040192753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Methods of use of thrombin receptor antagonists'
[patent_app_type] => new
[patent_app_number] => 10/705282
[patent_app_country] => US
[patent_app_date] => 2003-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12959
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20040192753.pdf
[firstpage_image] =>[orig_patent_app_number] => 10705282
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/705282 | Methods of use of thrombin receptor antagonists | Nov 9, 2003 | Abandoned |
Array
(
[id] => 4487866
[patent_doc_number] => 07884221
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-08
[patent_title] => 'Method of separating ergosterol'
[patent_app_type] => utility
[patent_app_number] => 10/532682
[patent_app_country] => US
[patent_app_date] => 2003-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2977
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/884/07884221.pdf
[firstpage_image] =>[orig_patent_app_number] => 10532682
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/532682 | Method of separating ergosterol | Nov 6, 2003 | Issued |
Array
(
[id] => 5711009
[patent_doc_number] => 20060052354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Methods for treating migraine'
[patent_app_type] => utility
[patent_app_number] => 10/533146
[patent_app_country] => US
[patent_app_date] => 2003-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10321
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20060052354.pdf
[firstpage_image] =>[orig_patent_app_number] => 10533146
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/533146 | Methods for treating migraine | Nov 4, 2003 | Abandoned |
Array
(
[id] => 7163262
[patent_doc_number] => 20050085454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Phenolic antioxidant-chromium complexes for treatment or prevention of type 2 diabetes or glucose intolerance'
[patent_app_type] => utility
[patent_app_number] => 10/686801
[patent_app_country] => US
[patent_app_date] => 2003-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7889
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0085/20050085454.pdf
[firstpage_image] =>[orig_patent_app_number] => 10686801
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/686801 | Phenolic antioxidant-chromium complexes for treatment or prevention of type 2 diabetes or glucose intolerance | Oct 15, 2003 | Abandoned |
Array
(
[id] => 5748426
[patent_doc_number] => 20060111358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Treatment of aml'
[patent_app_type] => utility
[patent_app_number] => 10/530452
[patent_app_country] => US
[patent_app_date] => 2003-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5955
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20060111358.pdf
[firstpage_image] =>[orig_patent_app_number] => 10530452
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/530452 | Treatment of aml | Oct 6, 2003 | Abandoned |
Array
(
[id] => 5799156
[patent_doc_number] => 20060034780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Dental compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 10/528828
[patent_app_country] => US
[patent_app_date] => 2003-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4934
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20060034780.pdf
[firstpage_image] =>[orig_patent_app_number] => 10528828
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/528828 | Dental compositions and methods | Sep 22, 2003 | Abandoned |
Array
(
[id] => 5866009
[patent_doc_number] => 20060100140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Combination of a) n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]2-methylphenyl}-4- (3-pyridyl)-2-pyrimidine-amine and b) a histone deacetylase inhibitor for the treatment of leukemia'
[patent_app_type] => utility
[patent_app_number] => 10/527553
[patent_app_country] => US
[patent_app_date] => 2003-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11863
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20060100140.pdf
[firstpage_image] =>[orig_patent_app_number] => 10527553
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/527553 | Combination of a) n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]2-methylphenyl}-4- (3-pyridyl)-2-pyrimidine-amine and b) a histone deacetylase inhibitor for the treatment of leukemia | Sep 9, 2003 | Abandoned |
Array
(
[id] => 6977369
[patent_doc_number] => 20050287085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Composition for improving the physico-chemical properties of apatite-based materials, uses thereof and method using same'
[patent_app_type] => utility
[patent_app_number] => 10/526581
[patent_app_country] => US
[patent_app_date] => 2003-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4120
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20050287085.pdf
[firstpage_image] =>[orig_patent_app_number] => 10526581
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/526581 | Composition for improving the physico-chemical properties of apatite-based materials, uses thereof and method using same | Sep 3, 2003 | Abandoned |
Array
(
[id] => 5720382
[patent_doc_number] => 20060073156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Fosfomycin and n-acetylcysteine for the treatment of biofilms caused by escheric ia coli and other pathogens of the urinary tract'
[patent_app_type] => utility
[patent_app_number] => 10/526404
[patent_app_country] => US
[patent_app_date] => 2003-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1615
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20060073156.pdf
[firstpage_image] =>[orig_patent_app_number] => 10526404
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/526404 | Fosfomycin and n-acetylcysteine for the treatment of biofilms caused by escheric ia coli and other pathogens of the urinary tract | Aug 31, 2003 | Abandoned |
Array
(
[id] => 6952953
[patent_doc_number] => 20050228048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Stable eye drops containing latanoprost as the active ingredient'
[patent_app_type] => utility
[patent_app_number] => 10/524996
[patent_app_country] => US
[patent_app_date] => 2003-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3097
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20050228048.pdf
[firstpage_image] =>[orig_patent_app_number] => 10524996
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/524996 | Stable eye drops containing latanoprost as the active ingredient | Aug 21, 2003 | Abandoned |
Array
(
[id] => 5786873
[patent_doc_number] => 20060205809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease'
[patent_app_type] => utility
[patent_app_number] => 10/525500
[patent_app_country] => US
[patent_app_date] => 2003-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3738
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205809.pdf
[firstpage_image] =>[orig_patent_app_number] => 10525500
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/525500 | Pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease | Aug 19, 2003 | Abandoned |